Home › Calculator › SCNX Dividend Calculator 2026
SCNX Dividend DRIP Calculator 2026
540.83% YieldHealthcareScienture Holdings, Inc. · NASDAQ
Price: $0.37 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When SCNX pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your SCNX snowball 📈
$10,000 in SCNX → $9012630134042063872.00M in 10 years · $750,916,920,800,390,600,000,000.00/month
About Scienture Holdings, Inc. (SCNX) — Dividend Analysis 2026
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen. It also develops SCN-106, which is a thrombolytic agent that binds to fibrin in clots and converts entrapped plasminogen to plasmin; and SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional analgesia. Scienture Holdings, Inc. is headquartered in Commack, New York.
Compare SCNX with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full SCNX DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open SCNX position with:
🌍 SCNX Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold SCNX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 540.83% | 538.03% | $54,083 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 459.71% | 456.91% | $45,971 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 432.66% | 429.86% | $43,266 / yr |
| 🇬🇧 UK ISA | 0% | 540.83% | 538.03% | $54,083 / yr |
| 🇬🇧 UK Taxable | 8.75% | 493.51% | 490.71% | $49,351 / yr |
| 🇨🇦 TFSA | 0% | 540.83% | 538.03% | $54,083 / yr |
| 🇨🇦 CA Taxable | 25% | 405.62% | 402.82% | $40,562 / yr |
| 🇦🇺 Super (pension) | 15% | 459.71% | 456.91% | $45,971 / yr |
| 🇦🇺 AU Taxable | 30% | 378.58% | 375.78% | $37,858 / yr |
| 🇩🇪 DE Taxable | 26.375% | 398.19% | 395.39% | $39,819 / yr |
| 🇫🇷 FR Taxable | 30% | 378.58% | 375.78% | $37,858 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 SCNX Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 SCNX Dividend Payment Schedule
SCNX pays quarterly — 4 times per year. Next ex-div: TBD.
📊 SCNX vs Healthcare Benchmarks
How SCNX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SCNX sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ SCNX Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-02-20 | 500,000 | — | — | ||
| A-Award | 2025-10-01 | 300,000 | — | — | ||
| A-Award | 2025-04-14 | 750,000 | — | — | ||
| C-Conversion | 2024-09-19 | 1,916,816 | $0.00 | $19.00 | ||
| J-Other | 2025-03-10 | 30,000 | — | — | ||
| C-Conversion | 2024-09-19 | 356,480 | $0.00 | $4.00 | ||
| C-Conversion | 2024-09-19 | 356,480 | — | — | ||
| A-Award | 2026-02-20 | 500,000 | — | — | ||
| C-Conversion | 2024-09-19 | 1,357,538 | $0.00 | $14.00 | ||
| J-Other | 2025-03-10 | 20,000 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where SCNX earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SCNX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Scienture Holdings, Inc. (SCNX) is currently trading at $0.37, 95% below its 52-week high. The current dividend yield is 540.83% based on an annual payout of $2.00 per share.
SCNX (Scienture Holdings, Inc.) — 540.83% Dividend Yield Analysis
Scienture Holdings, Inc. (SCNX) is a healthcare stock currently trading at $0.37 with a dividend yield of 540.83%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (540.83%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.